Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

285

Citations

25

References

2013

Year

Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj, Eva Havrdová, Xavier Montalbán, Ernst‐Wilhelm Radue, Dusan Stefoski, Randy Robinson, Katherine Riester, Jitesh Rana,

Relapsing-remitting Multiple SclerosisClinical TrialsTreatment OptionPlacebo-controlled TrialPharmacotherapyNeurologyMultiple SclerosisDaclizumab High-yield ProcessMedicineNovel Therapy

References

	Year	Citations

Page 1

Page 1